BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38261128)

  • 1. Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
    Laws A; Leonard S; Hershey E; Stokes S; Vincuilla J; Sharma E; Milliron K; Garber JE; Merajver SD; King TA; Pilewskie ML
    Ann Surg Oncol; 2024 May; 31(5):3120-3127. PubMed ID: 38261128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
    Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
    AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
    [No Abstract]   [Full Text] [Related]  

  • 3. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
    Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
    Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
    McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
    Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
    Kunju LP; Kleer CG
    Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
    Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
    Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
    Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
    Okamoto S; Chen ST; Covelli JD; DeMartini WB; Daniel BL; Ikeda DM
    Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates.
    Tozbikian G; George M; Zynger DL
    Diagn Pathol; 2019 Jun; 14(1):69. PubMed ID: 31253155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flat Epithelial Atypia in Breast Core Needle Biopsies With Radiologic-Pathologic Concordance: Is Excision Necessary?
    Grabenstetter A; Brennan S; Salagean ED; Morrow M; Brogi E
    Am J Surg Pathol; 2020 Feb; 44(2):182-190. PubMed ID: 31609784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
    Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
    J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.
    Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S
    Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
    Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
    Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?
    Amin AL; Fan F; Winblad OD; Larson KE; Wagner JL
    Ann Surg Oncol; 2020 Nov; 27(12):4786-4794. PubMed ID: 32705514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
    Willers N; Neven P; Floris G; Colpaert C; Oldenburger E; Han S; Van Ongeval C; Smeets A; Duhoux FP; Wildiers H; Denolf P; Laudus N; Dequeker E; De Brabander I; Van Damme N; De Schutter H
    Clin Breast Cancer; 2023 Jun; 23(4):e273-e280. PubMed ID: 37085379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flat Epithelial Atypia on Core Biopsy and Upgrade to Cancer: a Systematic Review and Meta-Analysis.
    Rudin AV; Hoskin TL; Fahy A; Farrell AM; Nassar A; Ghosh K; Degnim AC
    Ann Surg Oncol; 2017 Nov; 24(12):3549-3558. PubMed ID: 28831724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision.
    Bahl M; Barzilay R; Yedidia AB; Locascio NJ; Yu L; Lehman CD
    Radiology; 2018 Mar; 286(3):810-818. PubMed ID: 29039725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy.
    Chaudhary S; Lawrence L; McGinty G; Kostroff K; Bhuiya T
    Mod Pathol; 2013 Jun; 26(6):762-71. PubMed ID: 23307062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
    Everidge SA; Sun J; Teshome M; Tamirisa N; Sun S; Adesoye T; Nia E; Bevers T; Bedrosian I; Patel M; Singh P
    Ann Surg Oncol; 2024 Apr; 31(4):2224-2230. PubMed ID: 38117388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model.
    Linsk A; Mehta TS; Dialani V; Brook A; Chadashvili T; Houlihan MJ; Sharma R
    Breast J; 2018 Mar; 24(2):115-119. PubMed ID: 28833923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.